Thiogenesis Therapeutics (Q8M.F) Q2 2026 Earnings

26MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.03
-0.02
-0.02
-0.01

Details

Expected EPS
N/A
Actual EPS
-0.01235248344
Surprise EPS
-0.01
Surprise Percent
+∞%

Description

Thiogenesis Therapeutics (Q8M.F) has reported earnings of -0.01235248344 per share for Q2 2026.

0 Comments

Share your thoughts